Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1Breast 1

Conditions

Pain, Procedural 1Neoplasms 1Hematologic Neoplasms 1Chronic Disease 1Anxiety Disorders 1Anemia, Sickle Cell 1

Interventions

Cytarabine 465Cyclophosphamide 459fludarabine phosphate 277Rituximab 249Methotrexate 245Etoposide 203fludarabine 200Filgrastim 199Peripheral Blood Stem Cell Transplantation 180Busulfan 169Vincristine 163Dexamethasone 153Daunorubicin 151Azacitidine 145Mycophenolic Acid 142Whole-Body Irradiation 133Tacrolimus 127Imatinib Mesylate 127Cyclosporine 123Granulocyte Colony-Stimulating Factor 118Radiotherapy 113Melphalan 110Idarubicin 103Doxorubicin 101Mitoxantrone 97Decitabine 97Antilymphocyte Serum 97Lenalidomide 96Mercaptopurine 93Prednisone 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Imagery, Psychotherapy × Other hematologic neoplasm × Clear all
NCT04892160 2021-05-19

Distracting Through Procedural Pain and Distress

Medical College of Wisconsin

Phase NA Completed
67 enrolled
Classical hematologyOther hematologic neoplasm

Pain, Procedural, Anemia, Sickle Cell, Anxiety Disorders, Chronic Disease, Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡